New Prostate Cancer Targets for Diagnosis, Imaging, and Therapy: Focus on Prostate-Specific Membrane Antigen
The rising incidence rate of the cancer in the prostate gland has increased the demand for improved diagnostic, imaging, and therapeutic approaches. Prostate-specific membrane antigen (PSMA), with folate hydrolase and carboxypeptidase and, internalization activities, is highly expressed in the epith...
Main Authors: | Alessia Cimadamore, Monica Cheng, Matteo Santoni, Antonio Lopez-Beltran, Nicola Battelli, Francesco Massari, Andrea B. Galosi, Marina Scarpelli, Rodolfo Montironi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2018.00653/full |
Similar Items
-
Treating Prostate Cancer by Antibody-Drug Conjugates
by: Matteo Rosellini, et al.
Published: (2021-02-01) -
Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen Receptor
by: Mahmoud Hassani, et al.
Published: (2020-03-01) -
Targeting prostate cancer with synthetic RNA ligands
by: Thomas, Gregory Stuart
Published: (2012) -
PSMA-D4 Radioligand for Targeted Therapy of Prostate Cancer: Synthesis, Characteristics and Preliminary Assessment of Biological Properties
by: Piotr Garnuszek, et al.
Published: (2021-03-01) -
Editor’s Pick: PSMA-Specific Ligands in Prostate Cancer Diagnosis and Therapy
by: Wei Jin, et al.
Published: (2016-04-01)